National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Cited by (1,029)

Items 501–600 of 1,029

1. Identification of neurotoxic cytokines by profiling Alzheimer’s disease tissues and neuron culture viability screening
   Levi Benjamin Wood, Ashley R. Winslow, Elizabeth A. Proctor, Declan McGuone, Daniel A. Mordes, Matthew P. Frosch, Bradley T. Hyman, Douglas A. Lauffenburger, Kevin M. Haigis · 2015 · Scientific Reports
2. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update
   Karim Farid, Andreas Charidimou, Jean‐Claude Baron · 2017 · NeuroImage Clinical
3. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features
   Eleanna Kara, Helen Ling, Alan Michael Pittman, Karen Shaw, Rohan de Silva, Roberto Simone, Janice L. Holton, Jason D. Warren, Jonathan Daniel Rohrer, Georgia Xiromerisiou et al. · 2012 · Neurobiology of Aging
4. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
   Dustin Wooten, Nicolas J. Guehl, Eline E. Verwer, Timothy M. Shoup, Daniel L. Yokell, Nevena Zubcevik, Neil Vasdev, ROSS D. ZAFONTE, Keith A. Johnson, Georges El Fakhri et al. · 2016 · Journal of Nuclear Medicine
5. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
   Irene Sintini, Peter R. Martin, Jonathan Graff‐Radford, Matthew L. Senjem, Christopher G. Schwarz, Mary M. Machulda, Anthony J. Spychalla, Daniel A. Drubach, David S. Knopman, Ronald Carl Petersen et al. · 2019 · NeuroImage Clinical
6. A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
   Antoine Leuzy, Tharick Ali Pascoal, Olof T. Strandberg, Philip S. Insel, Ruben A Smith, Niklas Mattsson, Andréa Lessa Benedet, Hanna Cho, Chul Hyoung Lyoo, Renaud La Joie et al. · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
7. The MAPT H1 haplotype is associated with tangle-predominant dementia
   Ismael Santa‐María, Aya M. Haggiagi, Xinmin Liu, Jessica Wasserscheid, Peter T. Nelson, Ken Dewar, Lorraine N. Clark, John F. Crary · 2012 · Acta Neuropathologica
8. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease
   Ian R. Macdonald, Selena P. Maxwell, George Andrew Reid, Meghan K. Cash, Drew R. DeBay, Sultan Darvesh · 2017 · Journal of Alzheimer s Disease
9. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques
   Monsell, Sarah E., Kukull, Walter A., Roher, Alex E., Maarouf, Chera L., Serrano, Geidy, Beach, Thomas G., Caselli, Richard J., Montine, Thomas J., Reiman, Eric M. · 2015 · JAMA Neurology
10. Standardized Operational Protocol for Human Brain Banking in China
    Wenying Qiu, Hanlin Zhang, Ai‐Min Bao, Keqing Zhu, Yue Ming Huang, Xiao‐Xin Yan, Jing Zhang, Chunjiu Zhong, Yong Shen, Jiang‐Ning Zhou et al. · 2018 · Neuroscience Bulletin
11. The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
    Arthur C. Macedo, Cécile Tissot, Joseph Therriault, Stijn Servaes, Yi-Ting Wang, Jaime Fernández Arias, Nesrine Rahmouni, Firoza Zubeida Lussier, Marie R. Vermeiren, Gleb Bezgin et al. · 2023 · Journal of Nuclear Medicine
12. Aphasic variant of Alzheimer disease
    Emily Joy Rogalski, Jaiashre Sridhar, Benjamin M. Rader, Adam Martersteck, Kewei Chen, Derin J. Cobia, Cynthia K. Thompson, Sandra Weıntraub, Eileen H. Bigio, Marsel M. Mesulam · 2016 · Neurology
13. Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity
    Neng‐Wei Hu, Grant T. Corbett, Steven Moore, Igor V. Klyubin, Tiernan T. O’Malley, Dominic M. Walsh, Frederick J. Livesey, Michael J. Rowan · 2018 · Cell Reports
14. Systemic infection modifies the neuroinflammatory response in late stage Alzheimer’s disease
    Sonja Rakić, Yat M. A. Hung, Matthew Smith, Denise So, Hannah Mary Tayler, William Varney, Joe Wild, Scott Harris, Clive Holmes, Seth Love et al. · 2018 · Acta Neuropathologica Communications
15. RETRACTED: Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease
    Leela Paladugu, Abeer Gharaibeh, Nivya Kolli, Cameron R. Learman, Tia C. Hall, Lixin Li, Julien Rossignol, Panchanan Maiti, Gary Leo Dunbar · 2021 · International Journal of Molecular Sciences · Retracted
16. BIN1 Is Decreased in Sporadic but Not Familial Alzheimer’s Disease or in Aging
    Glennon, Elizabeth B. C., Whitehouse, Isobel J., Miners, J. Scott, Kehoe, Patrick G., Love, Seth, Kellett, Katherine A. B., Hooper, Nigel M. · 2013 · PLoS ONE
17. Deep learning-based identification of genetic variants: application to Alzheimer’s disease classification
    Jo, Taeho, Nho, Kwangsik, Bice, Paula, Saykin, Andrew J, For The Alzheimer’s Disease Neuroimaging Initiative · 2022 · Briefings in Bioinformatics
18. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease
    Chételat, Gaël, Ossenkoppele, Rik, Villemagne, Victor L., Perrotin, Audrey, Landeau, Brigitte, Mézenge, Florence, Jagust, William J., Dore, Vincent, Miller, Bruce L., Egret, Stéphanie et al. · 2016 · Brain
19. Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers
    Véronique Dorval, Peter T. Nelson, Sébastien S. Hébert · 2013 · Frontiers in Molecular Neuroscience
20. Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau
    Keith A. Josephs · 2017 · Mayo Clinic Proceedings
21. An update on the interactions between Alzheimer's disease, autophagy and inflammation
    Mehmet Bostancıklıoğlu · 2019 · Gene
22. Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study
    Megan A. Iida, Kurt W. Farrell, Jamie M. Walker, Timothy E. Richardson, Gabriel A. Marx, Clare Bryce, Dushyant P. Purohit, Gai Ayalon, Thomas G. Beach, Eileen H. Bigio et al. · 2021 · Acta Neuropathologica Communications
23. The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
    Russell Howard Swerdlow · 2023 · Journal of Alzheimer s Disease
24. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease
    Young, Christina B., Winer, Joseph R., Younes, Kyan, Cody, Karly A., Betthauser, Tobey J., Johnson, Sterling C., Schultz, Aaron, Sperling, Reisa A., Greicius, Michael D., Cobos, Inma et al. · 2022 · JAMA Neurology
25. Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
    Bryant, Annie G., Hu, Miwei, Carlyle, Becky C., Arnold, Steven E., Frosch, Matthew P., Das, Sudeshna, Hyman, Bradley T., Bennett, Rachel E. · 2020 · Frontiers in Neurology
26. Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome
    Panagiotis Zis, André Strydom · 2017 · Free Radical Biology and Medicine
27. Diagnostic Accuracy of Amyloid versus18F‐Fluorodeoxyglucose Positron Emission Tomography in Autopsy‐Confirmed Dementia
    Orit H. Lesman‐Segev, Renaud La Joie, Leonardo Iaccarino, Iryna V. Lobach, Howard J. Rosen, Sang Won Seo, Mustafa Janabi, Suzanne L. Baker, Lauren Edwards, Julie Q. Pham et al. · 2020 · Annals of Neurology
28. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease
    Ana Rita Agra de Almeida Quadros, Zhaozhi Li, Xue Wang, I. Sandra Ndayambaje, Sandeep Aryal, Nandini Ramesh, Matthew Nolan, Rojashree Jayakumar, Yi Han, Hannah Stillman et al. · 2024 · Acta Neuropathologica
29. Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity
    Collins-Praino, Lyndsey E, Francis, Yitshak I, Griffith, Erica Y, Wiegman, Anne F, Urbach, Jonathan, Lawton, Arlene, Honig, Lawrence S, Cortes, Etty, Vonsattel, Jean Paul G, Canoll, Peter D et al. · 2014 · Acta Neuropathologica Communications
30. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series
    Koji Yoshida, Yukiko Hata, Koshi Kinoshita, Shutaro Takashima, Kortaro Tanaka, Naoki Nishida · 2017 · Acta Neuropathologica
31. Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
    Swarup, Vivek, Chang, Timothy S., Duong, Duc M., Dammer, Eric B., Dai, Jingting, Lah, James J., Johnson, Erik C.B., Seyfried, Nicholas T., Levey, Allan I., Geschwind, Daniel H. · 2020 · Cell Reports
32. (−)-P7C3-S243 Protects a Rat Model of Alzheimer’s Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia
    Voorhees, Jaymie R., Remy, Matthew T., Cintrón-Pérez, Coral J., El Rassi, Eli, Khan, Michael Z., Dutca, Laura M., Yin, Terry C., McDaniel, Latisha N., Williams, Noelle S., Brat, Daniel J. et al. · 2018 · Biological Psychiatry
33. Identification of conserved proteomic networks in neurodegenerative dementia
    Swarup, Vivek, Chang, Timothy S., Duong, Duc M., Dammer, Eric B., Lah, James J., Johnson, Erik E.C.B., Seyfried, Nicholas T., Levey, Allan I., Geschwind, Daniel H. · 2019
34. Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem study
    Ricardo Jorge Ferreira Taipa, Vítor Ferreira, Paulo Brochado, Andrew Robinson, I. Reis, Fernanda Marques, David M. A. Mann, Manuel Melo Pires, Nuno Sousa · 2017 · Neuropathology and Applied Neurobiology
35. Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype
    Jacob S. Friedberg, Nurgül Aytan, Jonathan D. Cherry, Weiming Xia, Oliver J. Standring, Victor E. Alvarez, Raymond Nicks, Sarah E. Svirsky, Gaoyuan Meng, Gyungah Jun et al. · 2020 · Scientific Reports
36. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
    Yvonne S. Eisele, Charles J. Duyckaerts · 2015 · Acta Neuropathologica
37. Label-free vibrational imaging of different Aβ plaque types in Alzheimer’s disease reveals sequential events in plaque development
    Röhr, Dominik, Boon, Baayla D. C., Schuler, Martin, Kremer, Kristin, Hoozemans, Jeroen J. M., Bouwman, Femke H., El-Mashtoly, Samir F., Nabers, Andreas, Großerueschkamp, Frederik, Rozemuller, Annemieke J. M. et al. · 2020 · Acta Neuropathologica Communications
38. A Luminex Assay Detects Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid
    A. Zara Herskovits, Joseph J. Locascio, Elaine R. Peskind, Ge Li, Bradley T. Hyman · 2013 · PLoS ONE
39. Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
    Michael A. Castello, John David Jeppson, Salvador Soriano · 2014 · BMC Neurology
40. Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18F]THK-5117 Positron Emission Tomography
    Aiko Ishiki, Nobuyuki Okamura, Katsutoshi Furukawa, Shozo Furumoto, Ryuichi Harada, Naoki Tomita, Kotaro Hiraoka, Shoichi Watanuki, Yoichi Ishikawa, Tetsuro Tago et al. · 2015 · PLoS ONE
41. Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
    Sally Hunter, Carol Brayne · 2017 · Journal of Negative Results in BioMedicine
42. Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
    Stéphane Epelbaum, Rémy Genthon, Enrica Cavedo, Marie Odile Habert, Foudil Lamari, Geoffroy Pierre Gagliardi, Simone Lista, Marc Teichmann, Hovagim Bakardjian, Harald Juergen Hampel et al. · 2017 · Alzheimer s & Dementia
43. Association of Genetic Variants With Primary Open-Angle Glaucoma Among Individuals With African Ancestry
    Michael A. Hauser, R. Rand Allingham, Tin Aung, Carly J. van der Heide, Kent D. Taylor, Jerome I. Rotter, Shih‐Hsiu J. Wang, Pieter W. M. Bonnemaijer, Susan Eileen Isabella Williams, Sadiq M. Abdullahi et al. · 2019 · JAMA
44. Protein contributions to brain atrophy acceleration in Alzheimer’s disease and primary age-related tauopathy
    Keith A. Josephs, Peter R. Martin, Stephen D. Weigand, Nirubol Tosakulwong, Marina Buciuc, Melissa Erin Murray, Leonard Petrucelli, Matthew L. Senjem, Anthony J. Spychalla, David S. Knopman et al. · 2020 · Brain
45. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline
    Jennifer S. Rabin, Emma Nichols, Renaud La Joie, Kaitlin Blackstone Casaletto, Priya Palta, Kristen Dams-O’Connor, Raj G. Kumar, Kristen M. George, Claudia Liliana Satizábal, Julie A. Schneider et al. · 2022 · Brain
46. Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer's Disease
    Annie G. Bryant, Zhaozhi Li, Rojashree Jayakumar, Alberto Serrano‐Pozo, Benjamin Woost, Miwei Hu, Maya E. Woodbury, Astrid Wachter, Gen Lin, Taekyung Kwon et al. · 2023 · Journal of Neuroscience
47. Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
    Gil Dan Rabinovici, David S. Knopman, Javier Arbizu, Tammie L.S. Benzinger, Kevin J. Donohoe, Oskar Hansson, Peter Herscovitch, Phillip H. Kuo, Jennifer Hagerty Lingler, Satoshi Minoshima et al. · 2025 · Journal of Nuclear Medicine
48. DNAJC12 and dopa‐responsive nonprogressive parkinsonism
    Letizia Straniero, Ilaria Guella, Roberto Cilia, Laura Parkkinen, Valeria Rimoldi, Alexander Young, Rosanna Asselta, Giulia Soldà, Vesna Sossi, A. Jon Stoessl et al. · 2017 · Annals of Neurology
49. Neurotoxic astrocytes express the d-serine synthesizing enzyme, serine racemase, in Alzheimer's disease
    Darrick T. Balu, Harry Pantazopoulos, Cathy Chia‐Yu Huang, Kevin Muszynski, Theresa L. Harvey, Yota Uno, Jacki M. Rorabaugh, Claire R. Galloway, Christian Alan Botz-Zapp, Sabina Berretta et al. · 2019 · Neurobiology of Disease
50. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease
    Geidy E. Serrano, J. Walkera, R Arce, Michael J. Glass, Daisy Vargas, Lucia I. Sue, Anthony J. Intorcia, Courtney M. Nelson, Javon Oliver, Jacopo Del Papa et al. · 2021 · medRxiv
51. Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond
    Maju Mathew Koola · 2020 · Psychiatry Research
52. Small RNA modifications in Alzheimer's disease
    Xudong Zhang, Fatima Trebak, Lucas A. C. Souza, Junchao Shi, Tong Zhou, Patrick G. Kehoe, Qi Chen, Yumei Feng · 2020 · Neurobiology of Disease
53. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation
    Luis Aragão Gomes, Valerie Uytterhoeven, Diego Lopez-Sanmartin, Sandra O. Tomé, Thomas Tousseyn, Rik R. Vandenberghe, Mathieu Vandenbulcke, Christine A. F. Von Arnim, Patrik Verstreken, Dietmar Rudolf Thal · 2021 · Acta Neuropathologica
54. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
    Sophie E Mastenbroek, Jacob W. Vogel, Lyduine Eisa Collij, Geidy E. Serrano, Cécilia Tremblay, Alexandra L. Young, Richard A. Arce, Holly A. Shill, Erika D. Driver‐Dunckley, Shyamal H. Mehta et al. · 2024 · Nature Communications
55. Pathology of clinical and preclinical Alzheimer’s disease
    Dietmar Rudolf Thal, Christine A. F. Von Arnim, W. Sue T. Griffin, Haruyasu Yamaguchi, Robert Emil Mrak, Johannes Attems, Ajeet Rijal Upadhaya · 2013 · European Archives of Psychiatry and Clinical Neuroscience
56. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype
    Shunsuke Koga, Naomi Kouri, Ronald L. Walton, Mark Ebbert, Keith A. Josephs, Irene Litvan, Neill R. Graff‐Radford, J. Eric Ahlskog, Ryan J. Uitti, Jay A. van Gerpen et al. · 2018 · Acta Neuropathologica
57. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics
    Jurre den Haan, Tjado H. J. Morrema, Annemieke J.M. Rozemüller, Femke H. Bouwman, Jeroen J.M. Hoozemans · 2018 · Acta Neuropathologica Communications
58. Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer’s Disease
    Dingding Mo, Xinping Li, Carsten Alexander Raabe, Timofey S. Rozhdestvensky, Boris V. Skryabin, Juergen Brosius · 2020 · Cells
59. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
    Konstantinos Chiotis, Laure Saint‐Aubert, Marina Boccardi, Anton Franz Gietl, Agnese Picco, Andrea Varrone, Valentina Garibotto, Karl Herholz, Flavio Mariano Nobili, Agneta K. Nordberg et al. · 2017 · Neurobiology of Aging
60. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
    On behalf of the European Early-Onset Dementia (EU EOD) consortium, De Roeck, Arne, Van den Bossche, Tobi, van der Zee, Julie, Verheijen, Jan, De Coster, Wouter, Van Dongen, Jasper, Dillen, Lubina, Baradaran-Heravi, Yalda, Heeman, Bavo et al. · 2017 · Acta Neuropathologica
61. Sleep as a Therapeutic Target in the Aging Brain
    Thierno Madjou Bah, James R. Goodman, Jeffrey J. Iliff · 2019 · Neurotherapeutics
62. Uncovering pathophysiological changes in frontotemporal dementia using serum lipids
    Katherine Phan, Ying Zi He, Russell Pickford, Surabhi Bhatia, Jared S. Katzeff, John R. Hodges, Olivier Piguet, Glenda Margaret Halliday, Woojin Scott Kim · 2020 · Scientific Reports
63. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment
    Magdalena Anna Koszewicz, Joanna Jaroch, Anna Brzecka, Maria Ejma, Sławomir P Budrewicz, Л.М. Михалева, Cristian Muresanu, Pamela Schield, Siva G. Somasundaram, Cecil E. Kirkland et al. · 2020 · Pharmacological Research
64. R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
    Ying Fan, Raja Sekhar Nirujogi, Alícia Garrido, Javier Ruiz‐Martínez, Alberto Bergareche‐Yarza, Elisabet Mondragón Rezola, Ana Vinagre‐Aragón, Ioana M. Croitoru, Ana Gorostidi Pagola, Laura Paternain Markinez et al. · 2021 · Acta Neuropathologica
65. A novel method for early diagnosis of Alzheimer’s disease based on pseudo Zernike moment from structural MRI
    Hamed Taheri Gorji, Javad Haddadnia · 2015 · Neuroscience
66. Dementia in the oldest old
    Zixuan Yang, Melissa Jane Slavin, Perminder Singh Sachdev · 2013 · Nature Reviews Neurology
67. Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
    Patrick J. Lao, Benjamin L. Handen, Tobey J. Betthauser, Iulia Mihaila, Sigan L. Hartley, Annie D. Cohen, Dana Tudorascu, Peter D. Bulova, Brian J. Lopresti, Rameshwari V. Tumuluru et al. · 2017 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
68. The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review
    Yun Freudenberg‐Hua, Wentian Li, Peter Davies · 2018 · Frontiers in Medicine
69. Proteomics of neurodegenerative diseases: analysis of human post‐mortem brain
    Ka Wan Li, Andrea B. Ganz, August Benjamin Smit · 2018 · Journal of Neurochemistry
70. Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
    Lee‐Way Jin, Jacopo Di Lucente, Hai Minh Nguyen, Vikrant Singh, Latika Singh, Monique Chavez, Trevor R. Bushong, Heike Wulff, Izumi Maezawa · 2019 · Annals of Clinical and Translational Neurology
71. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex
    Sepulcre, Jorge, Grothe, Michel J., Sabuncu, Mert, Chhatwal, Jasmeer, Schultz, Aaron P., Hanseeuw, Bernard, El Fakhri, Georges, Sperling, Reisa, Johnson, Keith A. · 2017 · JAMA Neurology
72. Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease
    Mann, David M. A., Davidson, Yvonne S., Robinson, Andrew C., Allen, Nancy, Hashimoto, Tadafumi, Richardson, Anna, Jones, Matthew, Snowden, Julie S., Pendleton, Neil, Potier, Marie-Claude et al. · 2018 · Acta Neuropathologica
73. Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study
    Rana April Eser, Alexander J. Ehrenberg, Cathrine Petersen, Sara Rose Dunlop, Maria B. Mejia, Cláudia Kimie Suemoto, Christine M. Walsh, Hima Rajana, Jun Yeop Oh, Panos Theofilas et al. · 2018 · Journal of Neuropathology & Experimental Neurology
74. Genomics and Functional Genomics of Alzheimer's Disease
    Kamboh, M. Ilyas · 2022 · Neurotherapeutics
75. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α‐synuclein pathology
    Shunsuke Koga, Maiko Ono, Naruhiko Sahara, Makoto Higuchi, Dennis W. Dickson · 2017 · Movement Disorders
76. Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
    Shieh‐Yueh Yang, Ming‐Jang Chiu, Ta‐Fu Chen, H. E. Horng · 2017 · Neurology and Therapy
77. Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force
    Jeffrey L. Cummings, Kaj Blennow, Keith A. Johnson, Michael B. Keeley, Randall John Bateman, José Luís Molinuevo, Jacques Touchon, Paul S. S. Aisen, Bruno J. Vellas · 2019 · The Journal of Prevention of Alzheimer s Disease
78. The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease
    David Hondius, Frank Koopmans, Conny Leistner, Débora Pita-Illobre, Regina M. B. Peferoen-Baert, Fenna Marbus, Iryna Paliukhovich, Ka Wan Li, Annemieke J.M. Rozemüller, Jeroen J.M. Hoozemans et al. · 2021 · Acta Neuropathologica
79. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia
    Chritica Lodder, Isabelle Scheyltjens, Ilie‐Cosmin Stancu, Pablo Botella Lucena, Manuel Gutiérrez de Ravé, Sarah Vanherle, Tim Vanmierlo, Niels Cremers, Hannah Vanrusselt, Bert Brône et al. · 2021 · Acta Neuropathologica Communications
80. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline
    Yu, Lei, Boyle, Patricia A., Leurgans, Sue, Schneider, Julie A., Bennett, David A. · 2014 · Neurobiology of Aging
81. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease
    Rayaprolu, Sruti, Gao, Tianwen, Xiao, Hailian, Ramesha, Supriya, Weinstock, Laura D., Shah, Jheel, Duong, Duc M., Dammer, Eric B., Webster, James A., Lah, James J. et al. · 2019
82. Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology
    Monsell, Sarah E., Mock, Charles, Hassenstab, Jason, Roe, Catherine M., Cairns, Nigel J., Morris, John C., Kukull, Walter · 2014 · Neurology
83. Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
    Chen, Shi-Dong, Lu, Jia-Ying, Li, Hong-Qi, Yang, Yu-Xiang, Jiang, Jie-Hui, Cui, Mei, Zuo, Chuan-Tao, Tan, Lan, Dong, Qiang, Yu, Jin-Tai et al. · 2021 · Translational Psychiatry
84. Distribution of Pathology in Frontal Variant Alzheimer's Disease
    Richard C. Blennerhassett, Patricia Lillo, Glenda Margaret Halliday, John R. Hodges, Jillian J. Kril · 2014 · Journal of Alzheimer s Disease
85. Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease
    Erik Abraham Williams, Declan McGuone, Matthew P. Frosch, Bradley T. Hyman, Nora Laver, Anat O Stemmer-Rachamimov · 2017 · Journal of Neuropathology & Experimental Neurology
86. Age-Dependent Changes to Sphingolipid Balance in the Human Hippocampus are Gender-Specific and May Sensitize to Neurodegeneration
    Timothy A. Couttas, Nupur Kain, Collin Tran, Zac Chatterton, John B. Kwok, Anthony Simon Don · 2018 · Journal of Alzheimer s Disease
87. Atherosclerosis, Hypertension, and Diabetes in Alzheimer’s Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation
    Keivan Javanshiri, Maria Landqvist Waldö, Niklas Friberg, Fredrik Sjövall, Karin Wickerström, Mattias Haglund, Elisabet M. Englund · 2018 · Journal of Alzheimer s Disease
88. Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images
    Christopher J. Buckley, Paul F. Sherwin, Adrian P L Smith, Jan Wolber, Sharon M. Weick, David James Brooks · 2016 · Nuclear Medicine Communications
89. Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies
    C. Latimer, C. Keene, Margaret E. Flanagan, L. Hemmy, Kelvin O. Lim, Lon R. White, K. Montine, T. Montine · 2017 · Journal of Neuropathology and Experimental Neurology
90. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy
    Marina Buciuc, Hugo Botha, Melissa Erin Murray, Christopher G. Schwarz, Matthew L. Senjem, David Thomas Jones, David S. Knopman, Bradley F. Boeve, Ronald Carl Petersen, Clifford R. Jack et al. · 2020 · Neurology
91. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy
    Si Jie Tang, Arman Fesharaki‐Zadeh, Hideyuki Takahashi, Sarah Helena Nies, Levi M. Smith, Anin Luo, Annabel S. Chyung, Marius Chiasseu, Stephen M. Strittmatter · 2020 · Acta Neuropathologica Communications
92. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
    Anne M. Fagan, Rachel L. Henson, Yan Li, Anna H. Boerwinkle, Chengjie Xiong, Randall John Bateman, Alison Goate, Beau M. Ances, Eric W. Doran, Bradley T. Christian et al. · 2021 · The Lancet Neurology
93. Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases
    Jun Yeop Oh, Christine M. Walsh, Kamalini G. Ranasinghe, Mihovil Mladinov, Felipe Luiz Pereira, Cathrine Petersen, Neus Falgàs, Leslie M. Yack, Tia LaMore, Rakin Tammam Nasar et al. · 2022 · JAMA Neurology
94. Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective
    Puneet Talwar, Juhi Sinha, Sandeep Grover, Chitra Rawat, Suman S. Kushwaha, Rachna Agarwal, Vibha Taneja, Ritushree Kukreti · 2015 · Molecular Neurobiology
95. Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders
    Shigeto Nagao, Osamu Yokota, Chikako Ikeda, Naoya Takeda, Hideki Ishizu, Shigetoshi Kuroda, Koichiro Sudo, Seishi Terada, Shigeo Murayama, Yosuke Uchitomi · 2013 · European Archives of Psychiatry and Clinical Neuroscience
96. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer’s disease
    Alzheimer’s Disease Neuroimaging Initiative, Tina Roostaei, Arash Nazeri, Daniel Felsky, Philip L. De Jager, Julie A. Schneider, Bruce G. Pollock, David Alan Bennett, Aristotle N. Voineskos · 2016 · Molecular Psychiatry
97. Stem cell therapies in age-related neurodegenerative diseases and stroke
    Yuan Wang, Xunming Ji, Rehana K. Leak, Fenghua Chen, Guodong Cao · 2016 · Ageing Research Reviews
98. VEGFR1 and VEGFR2 in Alzheimer’s Disease
    Rachel Harris, James Scott Miners, Shelley Jane Allen, Seth Love · 2017 · Journal of Alzheimer s Disease
99. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
    Clarissa Ferolla Mendonça, Magdalena Kuras, Fábio César Sousa Nogueira, Indira Plá, Tibor Hortobágyi, László Csiba, Miklós Palkovits, Éva Renner, Péter Döme, György Marko‐Varga et al. · 2019 · Neurobiology of Disease
100. Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging
     for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), Yan, Qi, Nho, Kwangsik, Del-Aguila, Jorge L., Wang, Xingbin, Risacher, Shannon L., Fan, Kang-Hsien, Snitz, Beth E., Aizenstein, Howard J., Mathis, Chester A. et al. · 2021 · Molecular Psychiatry